期刊文献+

连续性血液净化联合血液灌流在儿童溶血尿毒综合征中的应用 被引量:4

Application of continuous blood purification combined with hemoperfusion in the treatment of hemolytic-uremic syndrome in children
原文传递
导出
摘要 目的观察连续性血液净化(CBP)联合血液灌流(HP)治疗儿童溶血尿毒综合征(HUS)的疗效并初步探讨其治疗的可能机制。方法在内科治疗基础上,急性期均采用CBP联合HP治疗HUS患儿8例。治疗前后采用化学发光法检测血清IL-6、IL-8、TNF-α水平,并测定血尿素氮(BUN)、肌酐(SCr)、谷丙转氨酶(ALT)、谷草转氨酶(AST)、肌酸激酶(CK)、肌酸激酶同工酶(CKMB)、血红蛋白(Hb)、血小板(PLT)、C反应蛋白(CRP)等水平。8例健康体检儿童作为对照组。结果经CBP联合HP治疗后,8例HUS患儿均存活,病情好转;Hb、PLT水平较治疗前回升,血清IL-6、IL-8、TNF-α、BUN、SCr、ALT、CK、CRP水平较治疗前下降,差异有统计学意义(P<0.05)。结论 CBP联合HP治疗能迅速清除致病因子,又能持续清除炎症介质和毒素,逆转多脏器功能障碍,是治疗儿童HUS的有效方法之一。 Objective To observe the therapeutic effect of continuous blood purification (CBP) combined with hemoperfusion (HP) in children with hemolytic-uremic syndrome (HUS) and to investigate its possible mechanism. Methods Eight children with HUS received CBP combined with HP on the basis of internal medicine treatment in the acute stage. Before and after treatment, serum levels of interleukin-6 ( IL-6), IL-8 and tumor necrosis factor-a (TNF-a) were measured by chemiluminescence method, and levels of blood urea nitrogen (BUN) , serum creatinine (SCr) , alanine aminotransferase ( ALT), aspartate aminotransferase ( AST), creatine kinase ( CK), creatine kinase MB ( CKMB ), hemoglobin (Hb), platelet (PLT) and C-reactive protein (CRP) were measured. Eight healthy children undergoing physical examination were used as controls. Results The 8 children with HUS all survived after CBP combined with FIP and showed improved conditions. They had increased Hb and PLT levels and decreased serum levels of IL-6, IL-8, TNF-a, BUN, SCr, ALT, CK and CRP after treatment ( P 〈 0.05 ). Conclusions CBP combined with HP can quickly remove pathogenic factors, continually eliminate inflammatory mediators and toxins, and reverse multiple organ dysfunction, and is one of effective methods for treating HUS in children.
出处 《中国当代儿科杂志》 CAS CSCD 北大核心 2013年第1期53-55,共3页 Chinese Journal of Contemporary Pediatrics
基金 安徽省卫生厅临床医学技术应用项目(2008B075)
关键词 溶血尿毒综合征 连续性肾脏替代治疗 血液灌流 儿童 Hemolytic-uremic syndrome Continuous blood purification Hemoperfusion Child
  • 相关文献

参考文献13

  • 1赵季琳.溶血尿毒综合征[M]//胡亚美,江载芳.诸福堂实用儿科学(下册).第7版.北京:人民卫生出版社,2002:1659-1662.
  • 2Santiago MJ,López-Herce J,Urbano J,Solana MJ,del Castillo J,Ballestero Y,et al.Clinical course and mortality risk factors incritically ill children requiring continuous renal replacement thera-py[J].Intensive Care Med,2010,36(5):843-849.
  • 3Psotka MA,Obata F,Kolling GL,Gross LK,Saleem MA,Satch-ell SC,et al.Shiga toxin 2 targets the murine renal collecting ductepithelium[J].Infect Immun,2009,77(3):959-969.
  • 4Zoja C,Buelli S,Morigi M.Shiga toxin-associated hemolytic ure-mic syndrome:pathophysiology of endothelial dysfunction[J].Pe-diatr Nephrol,2010,25(11):2231-2240.
  • 5Stahl AL,Sartz L,Karpman D.Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Esch-erichia coli-induced hemolytid uremic syndrome[J].Blood,2011,117(20):5503-5513.
  • 6George JN,Terrell DR,Swisher KK,Vesely SK.Lessons learnedfrom the Oklahoma thrombotic thrombocytopenic purpura-hemolyticuremic syndrome registry[J].J Clin Apher,2008,23(4):129-137.
  • 7Fang CJ,Richards A,Liszewski MK,Kavanagh D,Atkinson JP.Advances in understanding of pathogenesis of aHUS and HELLP[J].Br J Haematol,2008,143(3):336-348.
  • 8Provaznikova D,Rittich S,Malina M,Seeman T,Marinov I,Riedl M,et al.Manifestation of atypical hemolytic uremic syn-drome caused by novel mutations in MCP[J].Pediatr Nephrol,2012,27(1):73-81.
  • 9Johnson S,Waters A.Is complements a culprit in infection-in-duced forms of haemolytic uraemic syndrome[J].Immunobiolo-gy,2011,26.[Epub ahead of print].
  • 10王质刚.血液净化新概念:血液净化理论与技术的新进展[J].中国血液净化,2008,7(2):59-60. 被引量:43

二级参考文献24

  • 1杨镒宇,郑亦男,曾萍,陶建平,洪婕,张剑晖,朱翠平,常平,曾其毅.危重症患儿血液净化治疗的并发症和意外事件与防治[J].中国实用儿科杂志,2007,22(5):376-379. 被引量:13
  • 2Lins RL,Elseviers MM,Van der Niepen P,Hoste E,MalbrainML,Damas P,et al.Inter-mittent versus continuous renal re-placement therapy for acute kidney injury patients admitted to theintensive care unit:results of a randomized clinical trial[J].Neph-rol Dial Transplant,2009,24(2):512-518.
  • 3Chen ZH,Liu ZH,Yu C,Ji DX,Li LS.Endothelial dysfunctionin patients with severe acute pancreatitis:improved by continuousblood purification therapy[J].Int J Artif Organs,2007,30(5):393-400.
  • 4Lopez Herce J,Santiago MJ,Solana MJ,Urbano J,del Castillo J,Carrillo A,et al.Clinical course of children requiring prolongedcontinuous renal replacement therapy[J].Pediatr Nephrol,2010,25(3):523-528.
  • 5Oudemans-van Straaten HM,Wester JP,de Pont AC,Schetz MR.Anticoagulation strategies in continuous renal replacement therapy:can the choice be evidence based?[J].Intensive Care Med,2006,32(2):188-202.
  • 6del Castillo J,López-Herce J,Cidoncha E,Urbano J,Mencia S,Santiago MJ,et al.Circuit life span in critically ill children oncontinuous renal replacement treatment:a prospective observationalevaluation study[J].Crit Care,2008,12(4):R93.
  • 7Ricci Z,Guzzo I,Picca S,Picardo S.Circuit lifespan during con-tinuous renal replacement therapy:children and adults are notequal[J].Crit Care,2008,12(5):178.
  • 8Ponikvar R,Kandus A,Urbancic A,Kornhauser AG,Primozic J,Ponikvar JB.Continuous renal replacement therapy and plasma ex-change in newborns and infants[J].Artif Organs,2002,26(2):163-168.
  • 9Santiago MJ,López-Herce J,Urbano J,Solana MJ,del Castillo J,Ballestero Y,et al.Complications of continuous renal replacementtherapy in critically ill children:a prospective observational evalu-ation study[J].Crit Care,2009,13(6):R184.
  • 10Yorgin P,Ludlow M,Chua A,Alexander S.A technique for rap-id exchange of continuous renal replacement therapy[J].PediatrNephrol,2006,21(5):743-746.

共引文献46

同被引文献31

引证文献4

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部